News

The priority review is based on results from a placebo-controlled Phase 3 trial evaluating ozanimod as a therapy for moderately to severely active ulcerative colitis.

Scripps Research, Florida has received a $1.8 million philanthropic gift from the William R. Kenan, Jr. Charitable Trust to support science education training.

Through their discovery, scientists expanded what's known about how the brain controls muscles and may have opened the door to potential treatments for children with certain rare disorders.

Scripps Research scientists engineer potentially safer glucocorticoids, a group of drugs used to treat COVID-19, auto-immune disease, and many other conditions.

Scripps Research President Peter Schultz calls for investment in the development of anti-viral drugs to combat viruses most likely to cause the next global pandemic.

Topol to be honored alongside Drs. Anthony Fauci and Wayne Riley, as well as hundreds of healthcare professionals for their dedication and compassion during the COVID-19 crisis.  

Structural studies reveal the role of an iron-rich molecule, heme, in bringing together gene transcription factors involved in sleep, immunity and metabolism.

Patapoutian is recognized for world-class research that provided the molecular basis for how temperature and pressure are perceived.

Findings suggest COVID-19 testing should be expanded to those without symptoms who may be unknowingly spreading the virus to others.

Schultz has made many innovative and pioneering contributions to the interface between chemistry and biology, including the rational expansion of the genetic code. 

Distraction can make you momentarily forget things. But how? Davis lab at Scripps Research, Florida uncovers a mechanism in fruit flies.

How a graduate student’s scientific illustrations have gone viral, leading to an award-winning video series.

Scripps Research President and CEO Peter Schultz, PhD, kicks off the 2021 Front Row lecture series with a talk on how the institute is accelerating drug development. 

Since the team's discovery, several additional cases of the B.1.1.7 coronavirus variant have been identified across California.

A new approach to gene therapy improves the efficiency of gene delivery.

Structural biologists developed the first detailed images of the coronavirus spike protein and then created a way to stabilize the protein for vaccines.  

In addition to addressing age-old questions on origin of life, the finding may lead to new practical applications in chemistry and biology.

The findings may enable better cancer treatments and new interventions for heart disease.

Made in clandestine laboratories and sold widely across the United States, the diverse class of drugs known as synthetic cannabinoids presents a growing public health threat.

The strategy relies on natural cancer-targeting cells of the immune system, called natural killer cells, that have been modified to selectively target lymphoma cells.

A new tool enables scientists to tackle difficult molecular recognition problems to aid drug discovery for incurable diseases.

A pioneering chemist, Yu's research has paved the way to powerful new techniques used in fields ranging from drug discovery to materials science.

The discovery of abnormal chemical reactions may lead to novel targets for drugs that treat neurodegenerative diseases.

More consumers are turning to quick DNA tests to learn their disease risks, but the scores they receive aren't always as precise as they could be.